GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AngioDynamics Inc (FRA:UG2) » Definitions » Cyclically Adjusted PB Ratio

AngioDynamics (FRA:UG2) Cyclically Adjusted PB Ratio : 0.38 (As of May. 25, 2024)


View and export this data going back to 2013. Start your Free Trial

What is AngioDynamics Cyclically Adjusted PB Ratio?

As of today (2024-05-25), AngioDynamics's current share price is €5.60. AngioDynamics's Cyclically Adjusted Book per Share for the quarter that ended in Feb. 2024 was €14.56. AngioDynamics's Cyclically Adjusted PB Ratio for today is 0.38.

The historical rank and industry rank for AngioDynamics's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:UG2' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.34   Med: 1.04   Max: 1.89
Current: 0.39

During the past years, AngioDynamics's highest Cyclically Adjusted PB Ratio was 1.89. The lowest was 0.34. And the median was 1.04.

FRA:UG2's Cyclically Adjusted PB Ratio is ranked better than
89.38% of 471 companies
in the Medical Devices & Instruments industry
Industry Median: 2.13 vs FRA:UG2: 0.39

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

AngioDynamics's adjusted book value per share data for the three months ended in Feb. 2024 was €5.015. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €14.56 for the trailing ten years ended in Feb. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


AngioDynamics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for AngioDynamics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioDynamics Cyclically Adjusted PB Ratio Chart

AngioDynamics Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.13 0.63 1.42 1.17 0.57

AngioDynamics Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 0.57 0.49 0.40 0.34

Competitive Comparison of AngioDynamics's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, AngioDynamics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AngioDynamics's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AngioDynamics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where AngioDynamics's Cyclically Adjusted PB Ratio falls into.



AngioDynamics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

AngioDynamics's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=5.60/14.56
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AngioDynamics's Cyclically Adjusted Book per Share for the quarter that ended in Feb. 2024 is calculated as:

For example, AngioDynamics's adjusted Book Value per Share data for the three months ended in Feb. 2024 was:

Adj_Book=Book Value per Share/CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=5.015/130.9299*130.9299
=5.015

Current CPI (Feb. 2024) = 130.9299.

AngioDynamics Quarterly Data

Book Value per Share CPI Adj_Book
201405 11.071 100.373 14.441
201408 11.416 100.352 14.894
201411 12.240 99.635 16.085
201502 13.351 99.032 17.651
201505 13.589 100.333 17.733
201508 13.598 100.548 17.707
201511 14.122 100.135 18.465
201602 13.714 100.040 17.949
201605 12.360 101.355 15.967
201608 12.448 101.617 16.039
201611 13.290 101.829 17.088
201702 13.576 102.779 17.294
201705 12.652 103.256 16.043
201708 11.846 103.587 14.973
201711 11.966 104.072 15.054
201802 11.730 105.052 14.620
201805 12.332 106.148 15.211
201808 12.586 106.383 15.490
201811 12.895 106.338 15.877
201902 12.987 106.649 15.944
201905 14.613 108.048 17.708
201908 14.532 108.245 17.578
201911 14.621 108.519 17.641
202002 14.707 109.139 17.643
202005 10.954 108.175 13.258
202008 10.034 109.662 11.980
202011 10.027 109.793 11.957
202102 9.770 110.968 11.527
202105 9.382 113.576 10.816
202108 9.497 115.421 10.773
202111 9.690 117.269 10.819
202202 9.669 119.703 10.576
202205 10.252 123.323 10.884
202208 10.352 124.958 10.847
202211 10.131 125.607 10.560
202302 9.378 126.928 9.674
202305 8.786 128.314 8.965
202308 9.755 129.538 9.860
202311 9.217 129.548 9.315
202402 5.015 130.930 5.015

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AngioDynamics  (FRA:UG2) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


AngioDynamics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of AngioDynamics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AngioDynamics (FRA:UG2) Business Description

Traded in Other Exchanges
Address
14 Plaza Drive, Latham, NY, USA, 12110
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, the company derives a majority of its revenue from the United States.

AngioDynamics (FRA:UG2) Headlines

No Headlines